Article
Japan Power Prices Surge To Highest Since 2023
Japan Power Prices Surge To Highest Since 2023
By Tsvetana Paraskova of OilPrice.com
Japan’s nationwide day-ahead electricity price soared by 20% in one week to settle on Monday at the highest level since January 2023, as gas supply disruptions from the Middle East and an intense heatwave pushed up prices and consumption.
The day-ahead power price in Japan has jumped to $0.16 (25.18 Japanese yen) per kilowatt-hour (kWh) on Monday, per data from the Japan Electric Power Exchange cited by Bloomberg.
The heatwave in Japan is set to intensify later this week,...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Apr 13, 2026 / Tyler Durden
Virginia Governor Signs Law Banning 'Ghost Guns'
Virginia Governor Signs Law Banning 'Ghost Guns'
Authored by Michael Clements via The Epoch Times,
Virginia Gov. Abigail Spanberger signed a bill to ban so-called “ghost guns,” another making it easier to sue gunmakers and sellers, and two other bills concerning possession of firearms by persons under court orders.
The bills - signed on April 10 - are among more than two dozen gun control and gun safety bills that the Virginia General Assembly sent to Spanberger after its regular session ended on March 24.
“Preventing gun violence is an issue of public...
Read more
Jul 12, 2026 / Dave DeCamp
Israel’s Netanyahu Recounts His ‘Last Conversation’ With Sen. Lindsey Graham
Israeli Prime Minister Benjamin Netanyahu on Sunday recounted what he said was his “last conversation” with Lindsey Graham, the notoriously hawkish South Carolina senator who died on Saturday night due to a “brief and sudden illness,” according to a statement from his office. Netanyahu said during an appearance on Fox News that the two discussed […]
Read more
Jun 22, 2026 / Tyler Durden
Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal
Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal
Definium Therapeutics shares surged as much as 54% on Monday, reaching $37.90 in morning trading as investors reacted positively to developments in the biotech company's research pipeline and potential strategic opportunities.
Definium Therapeutics said its LSD-based depression drug, DT120, met the main goal of a mid-stage trial, reducing depression scores by 8.1 points more than placebo after six weeks, according to Reuters.
Patients showed improvement within one week after a single dose, with benefits remaining at 12...
Read more




